Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reset Mind Sciences
West Perth, Western Australia, Australia
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Reset Mind Sciences is conducting psychedelic-assisted psychotherapy clinical trials in Western Australia, using psilocybin-assisted therapy for treatment-resistant mental health conditions, including a first-of-its-kind mental health clinical trial in Western Australia, with ongoing development of a proof-of-concept mental health facility model in partnership with an Australian health insurer.[1][2][8]
- Therapeutic areas
- Psychiatry
- Modalities
- Small moleculeNon-pharmacological therapy
- Industry
- Biotech
02
Partnerships
Little Green PharmaHIF (Health Insurance Fund of Australia)
Beyond the preview
Go deeper on Reset Mind Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reset Mind Sciences.